Replimune's stock surges 19% after-hours on FDA BLA submission By Investing.com

Published on 22 Nov 2024 on Investing.com

Shares of Replimune Group Inc (NASDAQ:REPL) surged more than 19% in after-hours trading following...

Read the rest of the article

Start tracking your investments with Statfolio

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherap...

Investing.com 25 Nov 2024

Tesla, Nvidia among Friday's market cap stock movers

Investing.com 22 Nov 2024

REPL stock soars after submitting a BLA to the FDA seeking accelerated approval for its lead...

Zacks · via Yahoo Finance 22 Nov 2024

Shares of Replimune Group Inc (NASDAQ:REPL) surged more than 19% in after-hours trading following...

Investing.com 22 Nov 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more tha...

Benzinga · via Yahoo Finance 22 Nov 2024

Tesla, Nvidia among Friday's market cap stock movers

Investing.com 22 Nov 2024

The shares were sold at a price of $10.78 each, amounting to a total transaction value of $78,111...

Investing.com 20 Nov 2024

According to a filing with the Securities and Exchange Commission, Sarchi sold 5,207 shares at a...

Investing.com 20 Nov 2024

Overview of the Recent Transaction On September 30, 2024, Morgan Stanley executed a significant t...

GuruFocus.com · via Yahoo Finance 8 Oct 2024

Thursday, Replimune Group Inc (NASDAQ:REPL) released topline results from the primary analysis of...

Benzinga · via Yahoo Finance 6 Jun 2024